26.98% to Target, Liberum Capital Reconfirms Buy Rating for Auto Trader Group Plc (LON:AUTO) Stock; Esperion Therapeutics, Inc. (ESPR) Had 10 Bullish Analysts

The financial company have set target price per share of GBX 480.00 on Auto Trader Group Plc (LON:AUTO) shares. This is 26.98% from the last stock close price. In a note sent to investors and clients on 15 March, Liberum Capital reconfirmed their Buy rating on shares of AUTO.

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Esperion Therapeutics has $153.0 highest and $10 lowest target. $65.88’s average target is -16.79% below currents $79.17 stock price. Esperion Therapeutics had 58 analyst reports since July 28, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of ESPR in report on Friday, November 6 with “Outperform” rating. The company was maintained on Thursday, June 30 by Needham. The rating was downgraded by Barclays Capital to “Equal-Weight” on Wednesday, June 29. As per Wednesday, February 21, the company rating was maintained by JP Morgan. The company was maintained on Tuesday, September 29 by Chardan Capital Markets. Lake Street maintained the shares of ESPR in report on Wednesday, June 29 with “Buy” rating. Stifel Nicolaus maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) rating on Monday, January 15. Stifel Nicolaus has “Buy” rating and $105.0 target. The firm has “Sector Perform” rating given on Wednesday, June 29 by RBC Capital Markets. UBS maintained it with “Buy” rating and $88.0 target in Wednesday, January 17 report. Needham upgraded Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Thursday, December 14 to “Buy” rating. See Esperion Therapeutics, Inc. (NASDAQ:ESPR) latest ratings:

08/03/2018 Broker: JMP Securities Rating: Buy New Target: $153.0
07/03/2018 Broker: Cowen & Co Rating: Buy New Target: $95.0 Maintain
21/02/2018 Broker: Needham Rating: Buy New Target: $94.0 Maintain
21/02/2018 Broker: UBS Old Rating: Neutral New Rating: Neutral Old Target: $88 New Target: $90 Maintain
21/02/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $55 New Target: $65 Maintain
22/01/2018 Broker: Citigroup Rating: Hold New Target: $96.0 Downgrade
17/01/2018 Broker: UBS Rating: Buy New Target: $88.0 Maintain
15/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $105.0 Maintain
05/01/2018 Broker: Bank of America Rating: Buy New Target: $76.0 Upgrade
14/12/2017 Broker: Needham Rating: Buy New Target: $81.0 Upgrade

Analysts await Auto Trader Group plc (LON:AUTO) to report earnings on May, 3. They expect $0.09 earnings per share, down 50.00% or $0.09 from last year’s $0.18 per share. AUTO’s profit will be $854,454 for 1053.89 P/E if the $0.09 EPS becomes a reality. After $-0.09 actual earnings per share reported by Auto Trader Group plc for the previous quarter, Wall Street now forecasts -200.00% EPS growth.

Auto Trader Group plc operates in the digital automotive marketplace in the United Kingdom and Ireland. The company has market cap of 3.60 billion GBP. It offers services and products to retailers and home traders to support its online activities. It has a 22.72 P/E ratio. The firm provides vehicle advertisement on its Websites for private sellers; and display advertising on its Websites for manufacturers and their advertising agencies, as well as insurance and loan financing products to consumers.

The stock decreased 1.13% or GBX 6.1 during the last trading session, reaching GBX 379.4. About 836,643 shares traded. Auto Trader Group plc (LON:AUTO) has 0.00% since March 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 20 analysts covering Auto Trader Group (LON:AUTO), 11 have Buy rating, 6 Sell and 3 Hold. Therefore 55% are positive. Auto Trader Group has GBX 530 highest and GBX 295 lowest target. GBX 410.72’s average target is 8.26% above currents GBX 379.4 stock price. Auto Trader Group had 125 analyst reports since August 19, 2015 according to SRatingsIntel. The stock has “Hold” rating by Deutsche Bank on Tuesday, October 24. Numis Securities maintained it with “Buy” rating and GBX 520 target in Thursday, February 1 report. The firm has “Hold” rating given on Tuesday, September 13 by Deutsche Bank. The firm has “Equal Weight” rating given on Wednesday, September 30 by Barclays Capital. The stock of Auto Trader Group plc (LON:AUTO) has “Underperform” rating given on Tuesday, May 9 by Credit Suisse. The rating was maintained by Peel Hunt on Friday, November 11 with “Buy”. The stock of Auto Trader Group plc (LON:AUTO) has “Underperform” rating given on Thursday, November 23 by Macquarie Research. The company was maintained on Friday, January 20 by Liberum Capital. BNP Paribas maintained the stock with “Outperform” rating in Wednesday, January 6 report. The stock of Auto Trader Group plc (LON:AUTO) earned “Buy” rating by Liberum Capital on Thursday, March 9.

Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol . The company has market cap of $2.10 billion. The Company’s lead product candidate is Bempedoic acid, an inhibitor of ATP-citrate lyase that reduces cholesterol biosynthesis that is in Phase III long-term safety and tolerability study. It currently has negative earnings.